Concepedia

Marlys Hammond

MH

Statistics

Publications

25

Citations

1.1K

H-Index

17

Active since

1990

Affiliations

GlaxoSmithKline (United States)(Current)

California Institute of Technology

Eli Lilly (United States)

Pfizer (United States)

Research Triangle Park Foundation

Marlys Hammond is an author at GlaxoSmithKline (United States) specializing in medicinal chemistry, pharmacology, and chemistry.

Publications per year

1990–2019

25

Publications

25

Development of a Small-Molecule Serum- and Glucocorticoid-Regulated Kinase-1 Antagonist and Its Evaluation as a Prostate Cancer Therapeutic

Andrea B. Sherk, Daniel E. Frigo, Christine G. Schnackenberg et al. · Cancer Research · 2008 · 214 citations · Full text

, , +17

Development of an Enantioselective Synthetic Route to Neocarzinostatin Chromophore and Its Use for Multiple Radioisotopic Incorporation

Andrew G. Myers, Ralf Glatthar, Marlys Hammond et al. · Journal of the American Chemical Society · 2002 · 85 citations

, , +10

Synthetic aspects of an asymmetric nitrogen-insertion process: preparation of chiral, non-racemic caprolactams and valerolactams. Total synthesis of (-)-alloyohimbane

Jeffrey Aubé, Yuguang Wang, Marlys Hammond et al. · Journal of the American Chemical Society · 1990 · 74 citations

, , +9

Total Synthesis of (+)-Neocarzinostatin Chromophore

Andrew G. Myers, Jun Liang, Marlys Hammond et al. · Journal of the American Chemical Society · 1998 · 62 citations

, , +8

Enantioselective Synthesis of Neocarzinostatin Chromophore Aglycon

Andrew G. Myers, Marlys Hammond, Yusheng Wu et al. · Journal of the American Chemical Society · 1996 · 61 citations

, , +6

1–5 of 25